Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease

ClinicalTrials.gov ID: NCT01430494

Public ClinicalTrials.gov record NCT01430494. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 12:25 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Longitudinal, Observational Study of Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) to Establish the Rate, Characteristics, and Determinants of Disease Progression

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To collect characteristics of patients with ADPKD across a broad population, over time to better understand disease progression (signs, symptoms and outcomes). Association with total kidney volume changes and other measures of disease progression will be determined in order to identify a population at increased risk for disease progression. The economic and quality life impact of ADPKD will be assessed. Subjects who terminated participation early from clinical trials with tolvaptan may also be followed.

Study identification

NCT ID
NCT01430494
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
3,409 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
12 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 1, 2011 (Actual)
Primary completion
Oct 1, 2014 (Actual)
Completion
Oct 1, 2014 (Actual)
Last update posted
Apr 28, 2026

2011 – 2014

United States locations

U.S. sites
102
U.S. states
36
U.S. cities
92
Facility City State ZIP Site status
Otsuka Investigational Site 1 Peoria Arizona 85381 —
Otsuka Investigational Site 2 Peoria Arizona 85381 —
Otsuka Investigational Site Tempe Arizona 85284 —
Otsuka Investigational Site Azusa California 91702 —
Otsuka Investigational Site Bakersfield California 93308 —
Otsuka Investigational Site Los Angeles California 90022 —
Otsuka Investigational Site Los Angeles California 90025 —
Otsuka Investigational Site Ontario California 91762 —
Otsuka Investigational Site San Diego California 92108 —
Otsuka Investigational Site Arvada Colorado 80002 —
Otsuka Investigational Site Aurora Colorado 80045 —
Otsuka Investigational Site Denver Colorado 80210 —
Otsuka Investigational Site New Haven Connecticut 06510 —
Otsuka Investigational Site Washington D.C. District of Columbia 20037 —
Otsuka Investigational Site Coral Gables Florida 33146 —
Otsuka Investigational Site Hudson Florida 34667 —
Otsuka Investigational Site Jacksonville Florida 32216 —
Otsuka Investigational Site Melbourne Florida 32935 —
Otsuka Investigational Site Port Charlotte Florida 33952 —
Otsuka Investigational Site Tampa Florida 33614 —
Otsuka Investigational Site Atlanta Georgia 30322 —
Otsuka Investigational Site Augusta Georgia 30901 —
Otsuka Investigational Site Meridian Idaho 83642 —
Otsuka Investigational Site Chicago Illinois 60637 —
Otsuka Investigational Site Peoria Illinois 61602 —
Otsuka Investigational Site Mishawaka Indiana 46545 —
Otsuka Investigational Site Kansas City Kansas 66106 —
Otsuka Investigational Site Wichita Kansas 67214 —
Otsuka Investigational Site Lexington Kentucky 40513 —
Otsuka Investigational Site Paducah Kentucky 42003 —
Otsuka Investigational Site New Orleans Louisiana 70121 —
Otsuka Investigational Site Baltimore Maryland 21201 —
Otsuka Investigational Site Baltimore Maryland 21224 —
Otsuka Investigational Site Bethesda Maryland 20814 —
Otsuka Investigational Site Rockville Maryland 20850 —
Otsuka Investigational Site Rockville Maryland 20852 —
Otsuka Investigational Site Wheaton Maryland 20906 —
Otsuka Investigational Site Boston Massachusetts 02111 —
Otsuka Investigational Site Boston Massachusetts 02215 —
Otuska Investigational Site Holyoke Massachusetts 01040 —
Otsuka Investigational Site Plymouth Massachusetts 02360 —
Otsuka Investigational Site Springfield Massachusetts 01107 —
Otsuka Investigational Site Detroit Michigan 48236 —
Otsuka Investigational Site Kalamazoo Michigan 49007 —
Otsuka Investigational Site Pontiac Michigan 48341 —
Otsuka Investigational Site Royal Oak Michigan 48073 —
Otsuka Investigational Site Brooklyn Center Minnesota 55430 —
Otsuka Investigational Site Rochester Minnesota 55905 —
Otsuka Investigational Site St Louis Missouri 63110 —
Otsuka Investigational Site Las Vegas Nevada 89106 —
Otsuka Investigational Site Las Vegas Nevada 89115 —
Otsuka Investigational Site Reno Nevada 89511 —
Otsuka Investigational Site Mount Laurel New Jersey 08054 —
Otsuka Investigational Site Princeton Junction New Jersey 08550 —
Otsuka Investigational Site Voorhees Township New Jersey 08043 —
Otsuka Investigational Site Albuquerque New Mexico 87109 —
Otsuka Investigational Site Albany New York 12208 —
Otsuka Investigational Site Brooklyn New York 11215 —
Otsuka Investigational Site Buffalo New York 14215 —
Otsuka Investigational Site Flushing New York 11355 —
Otsuka Investigational Site Forest Hills New York 11375 —
Otsuka Investigational Site Great Neck New York 11021 —
Otsuka Investigational Site Mineola New York 11501 —
Otsuka Investigational Site New York New York 10016 —
Otsuka Investigational Site New York New York 10021 —
Otsuka Investigational Site New York New York 10033 —
Otsuka Investigational Site Port Washington New York 11050 —
Otsuka Investigational Site Rochester New York 14642 —
Otsuka Investigational Site Rosedale New York 11422 —
Otsuka Investigational Site The Bronx New York 10467 —
Otsuka Investigational Site Chapel Hill North Carolina 27599 —
Otsuka Investigational Site Durham North Carolina 27705 —
Otsuka Investigational Site Winston-Salem North Carolina 27103 —
Otsuka Investigational Site Devils Lake North Dakota 58301 —
Otsuka Investigational Site Fargo North Dakota 58122 —
Otsuka Investigational Site Cincinnati Ohio 45267 —
Otsuka Investigational Site Cleveland Ohio 44106 —
Otsuka Investigational Site Columbus Ohio 43210 —
Otsuka Investigational Site Portland Oregon 97210 —
Otsuka Investigational Site Altoona Pennsylvania 16601 —
Otsuka Investigational Site Bethlehem Pennsylvania 18017 —
Otsuka Investigational Site Doylestown Pennsylvania 18901 —
Otsuka Investigational Site Lancaster Pennsylvania 17604 —
Otsuka Investigational Site Philadelphia Pennsylvania 19104 —
Otsuka Investigational Site Providence Rhode Island 02904 —
Otsuka Investigational Site Aiken South Carolina 29801 —
Otsuka Investigational Site Anderson South Carolina 29621 —
Otsuka Investigational Site Columbia South Carolina 29203 —
Otsuka Investigational Site Columbia South Carolina 29209 —
Otsuka Investigational Site Rapid City South Dakota 57701 —
Otsuka Investigational Site Knoxville Tennessee 37923 —
Otsuka Investigational Site Arlington Texas 76015 —
Otsuka Investigational Site Fort Worth Texas 76104 —
Otsuka Investigational Site Houston Texas 77004 —
Otsuka Investigational Site Houston Texas 77030 —
Otsuka Investigational Site Mission Texas 78572 —
Otsuka Investigational Site San Antonio Texas 78215 —
Otsuka Investigational Site Burlington Vermont 05401 —
Otsuka Investigational Site Fairfax Virginia 22030 —
Otsuka Investigational Site Bluefield West Virginia 24701 —
Otsuka Investigational Site Morgantown West Virginia 26506 —
Otsuka Investigational Site Madison Wisconsin 53713 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 164 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01430494, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2026 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01430494 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →